The wellbeing of our police is a priority for this Government, and we want to ensure that all officers have the appropriate support in place to thrive in their careers and continue to serve the public.

Through the Police Covenant, we have appointed the first Chief Medical Officer for policing who is developing a national health strategy for all staff and officers. We have also improved occupational health standards across all forces, introduced pre-deployment mental health training and continue to fund the National Police Wellbeing Service. The Service provides evidence-based guidance, advice, tools and resources to support forces and individual officers.

The Government also continues to work with the College of Policing, National Police Chiefs’ Council and senior leaders to ensure the right support is in place for officers with additional needs, disabilities or other health conditions by effectively adopting flexible work practices and workplace adjustments. The College of Policing has already provided specific support for line managers when considering reasonable adjustments, including a toolkit for forces to support the development of flexible and/or part-time working pathways, a Workplace Adjustment Toolkit and a disability passport.

Where an officer is assessed as permanently medically unfit and leaves the service, there are a range of benefits that may be payable under the occupational pension and injury benefit schemes, depending on the particular circumstances.

Like my Honourable Friend I am very keen to see the hoarding at the Brunswick site erected as soon as possible.

We have recently appointed Kier for precontract (design) services.

One of the first tasks they will undertake is the completion of the hoarding design.

We aim to have the hoarding proposals in place so that we may commence installation as soon as planning permission is granted.

As part of the HIV Action Plan, NHS England made an initial £20 million available over three years up to 2025 for human immunodeficiency virus (HIV) opt-out testing in 34 emergency departments in areas with extremely high HIV prevalence, with five or more HIV cases per 1,000 residents aged 15 to 59 years old. This includes Blackpool at 4.9 HIV cases in 2019, and the whole of London, including some local areas with high HIV prevalence, specifically with two to five HIV cases per 1,000 residents aged 15 to 59 years old, with additional funding from NHS London.

The programme shows extremely encouraging outcomes and in the first two years, it has preliminarily delivered nearly 1.9 million HIV tests, and helped find more than 1,000 people with undiagnosed or untreated HIV.

In November 2023, the Department announced a new research project to evaluate an expansion of HIV opt-out testing in emergency departments in England. Backed by a further £20 million of funding from the National Institute for Health and Care Research, the research project will evaluate the testing programme in 47 new sites across England, where HIV prevalence is high. The research project is currently in its set-up phase and will run until the end of 2025/26, with sites receiving twelve months of funding for testing.

Decisions on whether to continue offering opt-out HIV testing in emergency departments in local areas with extremely high and high HIV prevalence will be based on outcomes of the current opt-out HIV testing programme and research project, as well as available funding.

Both gonorrhoea and syphilis have returned to, and exceeded, the high levels reported in 2019, prior to the COVID-19 pandemic. Between 2021 and 2022, gonorrhoea increased in all age-groups, with the largest rise among young people aged 15 to 24 years old. Over the same period, infectious syphilis increased among gay, bisexual, or other men who have sex with men, and heterosexuals.

The UK Health Security Agency (UKHSA) conducts comprehensive surveillance of sexually transmitted infections and supports local authorities and sexual health services in using this data to inform sexual health service delivery. The UKHSA is undertaking work with partner organisations to identify the best use of existing and emerging preventative interventions, to address the increase in gonorrhoea and syphilis.

Both gonorrhoea and syphilis have returned to, and exceeded, the high levels reported in 2019, prior to the COVID-19 pandemic. Between 2021 and 2022, gonorrhoea increased in all age-groups, with the largest rise among young people aged 15 to 24 years old. Over the same period, infectious syphilis increased among gay, bisexual, or other men who have sex with men, and heterosexuals.

The UK Health Security Agency (UKHSA) conducts comprehensive surveillance of sexually transmitted infections and supports local authorities and sexual health services in using this data to inform sexual health service delivery. The UKHSA is undertaking work with partner organisations to identify the best use of existing and emerging preventative interventions, to address the increase in gonorrhoea and syphilis.

NHS England collects data on the number of people admitted to hospital with a palliative care diagnosis. However, this does not clearly indicate the reason for admission. The following table shows the numbers of patients identified as being admitted to hospital and having a palliative care diagnosis, for each of the past five years:

As part of the HIV Action Plan, we are committed to ensuring adequate support for those diagnosed and living with HIV. The most recent monitoring and evaluation report of the HIV Action Plan, published by the UK Health Security Agency, shows that in 2022, 76% of adults first diagnosed with HIV in England were linked to HIV care within two weeks, 87% within one month, and 93% within three months. This is an improvement compared to 2019.

NHS England’s specification for adult HIV services states that these services must have a policy describing how they aim to ensure retention in care, and re-engage those lost to care. A subgroup, Retention and Re-engagement in Care Task and Finish Group, of the HIV Action Plan Implementation Steering Group (ISG) is providing advice on increasing the number of people retained and re-engaged in care and receiving effective medical care, which will be considered by the ISG in due course.

As part of the HIV Action Plan, the NHS England HIV opt-out testing programme in emergency departments has identified 384 people previously diagnosed with HIV but who disengaged from care in the first 21 months, providing opportunities to re-engage those individuals in care. Given its success, the Department has recently committed an additional £20 million for new research, which will involve an expansion and evaluation of the programme in 47 additional emergency departments in local areas with high HIV prevalence, across England.

We remain committed to achieving equitable provision of HIV pre-exposure prophylaxis (PrEP) irrespective of gender, age, ethnicity, sexual orientation, disability, geographic area of residence, or socio-economic background. The HIV Action Plan Implementation Steering Group (ISG) published a roadmap in February 2024 to help guide efforts to improve access, uptake, and use of PrEP amongst key population groups at significant risk of HIV in England. An implementation working group of key delivery partners is being set up, which will monitor progress on actions and report back to the ISG.

Devolved administrations are responsible for developing and implementing their own public health strategies. Colleagues in England meet regularly with their counterparts in the devolved administrations, to share information and best practice on our response to HIV, including provision of PrEP.

Our commitment to PrEP as part of a combination approach is emphasised by our investment in the successful rollout of PrEP across England, where PrEP is routinely available in specialist sexual health services since March 2020, and we invested more than £34 million in PrEP in 2020/21 and 2021/22. PrEP funding has now been included within the Public Health Grant (PHG) since 2022/23, and funds appointments and testing in sexual health services, whilst NHS England covers the costs of the drug itself. The PHG is funded at £3.6 billion for 2024/25.

I thank my hon. Friend for bringing to the attention of the House the important initiatives going on in his patch in Darlington. Such local programmes have a huge impact in helping autistic people into work and tackling stigma. Once established, I am sure that the Buckland review task group will be interested to hear direct details of the work being done in his area.

We are continuing to run programmes to support autistic people into employment, including local supported employment, Disability Confident and Access to Work. The Department for Work and Pensions will also be working with stakeholders to support the independent task group carrying forward the recommendations following the Buckland review of autism employment.

The Independent Review of Children’s Social Care and the Competition and Markets Authority (CMA) recommended that the government introduces a network of Regional Care Cooperatives (RCCs) to plan, commission and deliver children’s social care placements in fostering, children’s homes and secure homes on a regional basis. The department has committed to trialling this approach with two RCC pathfinders to build an evidence base before future rollout.

The department’s long-term vision is that RCCs will help improve commissioning and sufficiency, and better enable local authorities to meet the needs of the children in their care, whilst reforming foster parent recruitment and retention.

In addition, the department is investing £36 million to deliver a fostering and retention programme so foster care is available for more children who need it. This will boost approvals of foster carers, as well as taking steps to retain existing foster carers. Darlington local authority, as part of the North East pathfinder, were one of the first local authorities to take part in this programme.

The requested data is not available.

Through the 2021 Drugs Strategy we are making the largest ever single increase in drug and alcohol treatment and recovery funding, with £780 million of additional investment. Of this, £532 million is being invested to rebuild local authority commissioned substance misuse treatment services in England. As alcohol and drug services are commissioned together, this will benefit people seeking treatment for alcohol use.

In the financial years 2022/23 to 2024/25, Darlington has been allocated just over £1.9 million through the Supplementary Substance Misuse Treatment and Recovery Grant and Inpatient Detoxification Grant, to increase the number of people benefiting from alcohol and drug treatment and recovery services, and the outcomes they achieve. This is additional to the amounts invested through the Public Health Grant.

Work in the National Health Service, specifically piloting early diagnosis and prevention through 19 community diagnostic hubs, is identifying undiagnosed liver disease. The North East and North Cumbria Integrated Care Board is enrolled in a Community Liver Health Check pilot in Newcastle, being delivered by the system’s Hepatitis C Operational Delivery Networks. This will provide FibroScans in one-stop community clinics, where patients also have other investigations, as required. The pilot has expanded into North Tyneside, and when resources allow, they intend to develop clinics elsewhere.

Beyond treatment, we are committed to tackling alcohol harms including reducing consumption levels, and in 2023 the Government introduced reforms to alcohol duty, meaning products are taxed directly in proportion to their alcohol content.

The Darlington economic campus is an important part of this Government’s operations and of our Government estate, but it is also important to the people of Darlington, and not just in terms of the jobs it has created. Of course, it builds on the back of significant funding on my hon. Friend’s watch: the £22 million town deal and the £6 million as part of the shared prosperity fund. That is one of the reasons why the people voted to elect Ben Houchen just the other day.

The below table shows the average weekly and yearly expenditure on the National Health Service in real terms and nominally, each year since 2016, including spending against the Revenue Departmental Expenditure Limit (RDEL) by NHS England, the integrated care boards, and providers:

Source: table 66 of the Department of Health and Social Care’s annual report.

Note: figures have been adjusted for inflation using HM Treasury’s gross domestic product deflators, as of April 2024.

UK Visas and Immigration (UKVI), as part of their compliance activities, conduct on-site audits of sponsors and check what assessment methods sponsors have used and their relevant evidence. Where there are any compliance breaches, UKVI take compliance action which can include formal action plans or revocation of the sponsor licence. English language assessments are also considered as part of the Basic Compliance Assessment which sponsors are required to pass on an annual basis.

It is an easy one! You are right, Mr Speaker: everyone should back Ben Houchen—

Funds recovered under the Proceeds of Crime Act (POCA) are distributed under the Home Office’s Asset Recovery Incentivisation Scheme (ARIS). The objective of ARIS is to provide agencies with incentives to use POCA powers to recover more criminal assets, with the overall aim of cutting crime and delivering justice.

Under the scheme, a proportion of the assets recovered using powers under POCA are redistributed to the agencies involved in the recovery, based on their relative contributions. The current allocation sees ARIS receipts split 50:50 between central government and operational partners.

In the spirit of the Scheme, the Government encourages agencies to use ARIS funds to increase asset recovery and, where appropriate, fund local crime fighting priorities for the benefit of the community. However, the use of ARIS allocations/payments is a matter for each agency and is left to their discretion. Further information on ARIS and how funds are spent can be found at: Asset Recovery Statistical Bulletin: Financial years ending March 2018 to March 2023 - GOV.UK (www.gov.uk).

No formal assessment has been made of the potential merits of providing lymphaticovenous anastomosis surgery on the National Health Service. On 16 April 2024, the National Institute for Health and Care Excellence (NICE) published interventional procedures guidance that states that lymphovenous anastomosis during axillary dissection for preventing secondary lymphoedema in adults with breast cancer, can be used in the NHS while more evidence is generated, and that it can only be used with special arrangements for clinical governance, consent and audit, or research. The NICE’s interventional procedures guidance makes recommendations for the NHS on whether procedures are sufficiently safe and efficacious for use in routine clinical practice.

Earlier this year, Defra published a report outlining the environmental concerns of disposable vapes. These products are an inefficient use of resources, are frequently disposed of incorrectly, can be harmful when littered and are difficult and costly to recycle. That is why on 29 January the Government confirmed that we would introduce a ban on single-use vapes. Draft regulations for the ban were published on 11 March with a proposed coming into force date of 1 April 2025 pending parliamentary procedures.